HS Icon Unpackaged Medicaments

Medicaments; (not goods of heading no. 3002, 3005 or 3006) of two or more constituents mixed together for therapeutic or prophylactic use not in measured doses or in forms or packings for retail sale

3003 (Harmonized System 1992 for 4-digit)

Overview This page contains the latest trade data of Unpackaged Medicaments. In 2020, Unpackaged Medicaments were the world's 295th most traded product, with a total trade of $10.6B. Between 2019 and 2020 the exports of Unpackaged Medicaments decreased by -5.27%, from $11.2B to $10.6B. Trade in Unpackaged Medicaments represent 0.064% of total world trade.

Unpackaged Medicaments are a part of Pharmaceutical products. They include Medicaments nes, formulated, in bulk, Antibiotics nes, formulated, in bulk, Hormones nes, no antibiotics, bulk, not contraceptive, Penicillins or streptomycins and derivatives, in bulk, Alkaloids, derivs, without antibiotics, hormones, bul, and Insulin, formulated, in bulk.

Exports In 2020 the top exporters of Unpackaged Medicaments  were United States ($1.58B), China ($880M), Germany ($848M), Switzerland ($740M), and Ireland ($739M).

Imports In 2020 the top importers of Unpackaged Medicaments were Ireland ($1.32B), Germany ($947M), United States ($747M), Belgium ($743M), and Netherlands ($585M).

Tariffs In 2018 the average tariff for Unpackaged Medicaments was 3.92%, making it the 1030th lowest tariff using the HS4 product classification.

The countries with the highest import tariffs for Unpackaged Medicaments are Iran (14.9%), Nepal (14.1%), and French Polynesia (13.4%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Ghana (0%), Guinea (0%), and Kenya (0%).

Ranking Unpackaged Medicaments ranks 296th in the Product Complexity Index (PCI).

Description Examples of medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses are antibiotics, which are used to treat bacterial infections, and vaccines, which are used to prevent diseases.

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Unpackaged Medicaments. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Historical Data

#permalink to section

Exporters and Importers

#permalink to section

Trade By Country

Top Origin (2020): United States, $1.58B

Top Destination (2020): Ireland, $1.32B

Unpackaged Medicaments are the world's 295th most traded product.

In 2020, the top exporters of Unpackaged Medicaments were United States ($1.58B), China ($880M), Germany ($848M), Switzerland ($740M), and Ireland ($739M).

In 2020, the top importers of Unpackaged Medicaments were Ireland ($1.32B), Germany ($947M), United States ($747M), Belgium ($743M), and Netherlands ($585M).

Explore Visualizations

Market Dynamics

#permalink to section

Trade by country

Value

Top Origin Growth (2019 -  2020): Ireland, $543M

Top Destination Growth (2019 - 2020): Belgium, $622M

Between 2019 and 2020, the exports of Unpackaged Medicaments grew the fastest in Ireland ($543M), Switzerland ($359M), United States ($304M), China ($107M), and Spain ($89.7M).

Between 2019 and 2020, the fastest growing importers of Unpackaged Medicaments were Belgium ($622M), Spain ($333M), Denmark ($161M), Germany ($140M), and United States ($121M).

Explore Visualizations

Market Concentration

#permalink to section

Cumulative market share

Value

This chart shows the evolution of the market concentration of exports of Unpackaged Medicaments.

In 2020,  market concentration measured using Shannon Entropy, was 4.63. This means that most of the exports of Unpackaged Medicaments are explained by 24 countries.

Explore Visualizations

TOP NET EXPORTER (2020): United States, $835M

TOP NET IMPORTER (2020): Ireland, $577M

This map shows which countries export or import more of Unpackaged Medicaments. Each country is colored based on the difference in exports and imports of Unpackaged Medicaments during 2020.

In 2020, the countries that had a largest trade value in exports than in imports of Unpackaged Medicaments were United States ($835M), China ($764M), Switzerland ($426M), Israel ($335M), and India ($302M).

In 2020, the countries that had a largest trade value in imports than in exports of Unpackaged Medicaments were Ireland ($577M), Belgium ($442M), Russia ($256M), Saudi Arabia ($229M), and Netherlands ($169M).

Disaggregation

#permalink to section
Value

In 2020, the world most traded Unpackaged Medicaments, disaggragated by their HS6 level were Medicaments nes, formulated, in bulk ($7.32B), Hormones nes, no antibiotics, bulk, not... ($1.37B), Antibiotics nes, formulated, in bulk ($1.12B), Penicillins or streptomycins and derivatives, in... ($445M), and Alkaloids, derivs, without antibiotics, hormones, bul ($265M)

Country Comparison

#permalink to section
Flow
Measure
Ranking

This visualization shows the countries that have an important ratio of their trade related to Unpackaged Medicaments.
It is possible to select the main countries that export or import Unpackaged Medicaments in the world, or by continent, as well as select the measure of interest.

Product Complexity

#permalink to section

Diversification Frontier

#permalink to section
Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Country by Relatedness

#permalink to section

The following visualization shows the relatedness of Unpackaged Medicaments to countries. Higher relatedness values ​​indicate greater knowledge, which predicts a greater probability of exporting that product in the future.